PMC:7172841 / 191-510 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":289,"end":299},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma63261"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"T5","span":{"begin":115,"end":123},"obj":"Disease"},{"id":"T6","span":{"begin":157,"end":175},"obj":"Disease"},{"id":"T7","span":{"begin":211,"end":219},"obj":"Disease"},{"id":"T8","span":{"begin":289,"end":319},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0021113"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005046"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1","span":{"begin":137,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T2","span":{"begin":300,"end":310},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":188,"end":204},"obj":"http://purl.obolibrary.org/obo/GO_0006955"},{"id":"T3","span":{"begin":289,"end":310},"obj":"http://purl.obolibrary.org/obo/GO_0042116"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-sentences","denotations":[{"id":"T6","span":{"begin":177,"end":249},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T3","span":{"begin":86,"end":105},"obj":"Phenotype"}],"attributes":[{"id":"A3","pred":"hp_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/HP_0002878"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T4","span":{"begin":86,"end":97},"obj":"UBERON:0001004"},{"id":"T5","span":{"begin":115,"end":123},"obj":"SP_7"},{"id":"T6","span":{"begin":157,"end":163},"obj":"UBERON:0002405"},{"id":"T7","span":{"begin":188,"end":194},"obj":"UBERON:0002405;GO:0006955"},{"id":"T8","span":{"begin":195,"end":204},"obj":"GO:0006955"},{"id":"T9","span":{"begin":211,"end":219},"obj":"SP_7"},{"id":"T10","span":{"begin":289,"end":299},"obj":"CL:0000235;GO:0042116"},{"id":"T11","span":{"begin":300,"end":310},"obj":"GO:0042116"},{"id":"T25589","span":{"begin":86,"end":97},"obj":"UBERON:0001004"},{"id":"T59726","span":{"begin":115,"end":123},"obj":"SP_7"},{"id":"T67700","span":{"begin":157,"end":163},"obj":"UBERON:0002405"},{"id":"T7839","span":{"begin":188,"end":194},"obj":"UBERON:0002405;GO:0006955"},{"id":"T23482","span":{"begin":195,"end":204},"obj":"GO:0006955"},{"id":"T94326","span":{"begin":211,"end":219},"obj":"SP_7"},{"id":"T55692","span":{"begin":289,"end":299},"obj":"CL:0000235;GO:0042116"},{"id":"T76896","span":{"begin":300,"end":310},"obj":"GO:0042116"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}

{"project":"LitCovid-PubTator","denotations":[{"id":"44","span":{"begin":220,"end":228},"obj":"Species"},{"id":"45","span":{"begin":254,"end":262},"obj":"Species"},{"id":"54","span":{"begin":86,"end":105},"obj":"Disease"},{"id":"55","span":{"begin":107,"end":110},"obj":"Disease"},{"id":"56","span":{"begin":115,"end":123},"obj":"Disease"},{"id":"57","span":{"begin":157,"end":175},"obj":"Disease"},{"id":"58","span":{"begin":211,"end":219},"obj":"Disease"},{"id":"59","span":{"begin":245,"end":248},"obj":"Disease"},{"id":"60","span":{"begin":268,"end":271},"obj":"Disease"},{"id":"61","span":{"begin":289,"end":319},"obj":"Disease"}],"attributes":[{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"Tax:9606"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:9606"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D012131"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:C000657245"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D007154"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C000657245"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D055501"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"dden clinical deterioration 7–8 days after initial symptom onset suggests that severe respiratory failure (SRF) in COVID-19 is driven by a unique pattern of immune dysfunction. We studied immune responses of 54 COVID-19 patients, 28 of whom had SRF. All patients with SRF displayed either macrophage activation syndrome"}